Research
Strategy
Overview
Overview
;
Patients are at the centre of OICR’s research strategy, which fosters an integrated translational research pathway that links cancer discoveries to patient impact.
In collaboration with our partners, we focus on developing the knowledge and tools to implement next-generation cancer precision medicine in Ontario.
For patients, this contributes to better cancer prevention, detection, diagnosis and treatment. Ultimately, this leads to improved patient survival and quality of life while also providing economic benefits for the people of Ontario.
Goals
Our overall research strategy is guided by these five overarching goals:
Advance early detection and intervention research
Reinforce Ontario’s global leadership in data sharing and analytics
Expand a robust pipeline of novel cancer therapeutics
Drive the translation and commercialization of cancer innovations in Ontario
Strengthen and sustain Ontario’s capacity for translational cancer research
Research blueprint
OICR conducts and facilitates research tackling cancer from multiple angles. Our efforts are grouped into three integrated themes:
Adaptive Oncology
Developing knowledge and approaches to detect and monitor cancer over its life cycle to enable precise and proactive clinical management.
Clinical Translation
Advancing Ontario cancer discoveries through early clinical validation, partnering with industry and the health system for downstream development and implementation of new treatments, diagnostics and biomarkers, thus fostering precision medicine for cancer patients.
Therapeutic Innovation
Validating novel cancer drug targets and advancing select therapeutic candidates towards clinical development.
OICR enables world-class translational cancer research in Ontario.
Talent Mobilization
Recruiting, developing and engaging outstanding Ontario cancer researchers and clinician-scientists.
Collaborative Research Resources
Providing access to cutting-edge research tools, assays, databases, expertise, resources and infrastructure.
Implementation Science
Supporting activities that promote the uptake of evidence-based practice and research into regular use by policymakers and healthcare providers.
Collaboration
Cancer is incredibly complex, so tackling it requires a team effort. Collaborative research is critical for maximizing the impact of our investment and achieving breakthroughs in patient care.
OICR actively collaborates with both the private and public sector, including pharmaceutical companies, biotechnology companies, venture capital firms, cancer centres, research institutes, hospitals, government agencies, academia and patients.
Interested in collaborating?
OICR investigators collaborate with the oncology research community in Ontario, across Canada and around the world.
Visit our Collaborative Research Resources directory, explore our programs or meet our researchers to find out more about opportunities to collaborate.
660+
organizations
Did you know?
OICR collaborates with people at 660+ organizations from 50 countries around the world
Looking Ahead
Receive the latest news, event invites, funding opportunities and more from the Ontario Institute for Cancer Research.